Facets (new session)
Description
Metadata
Settings
owl:sameAs
Inference Rule:
b3s
b3sifp
dbprdf-label
facets
http://dbpedia.org/resource/inference/rules/dbpedia#
http://dbpedia.org/resource/inference/rules/opencyc#
http://dbpedia.org/resource/inference/rules/umbel#
http://dbpedia.org/resource/inference/rules/yago#
http://dbpedia.org/schema/property_rules#
http://www.ontologyportal.org/inference/rules/SUMO#
http://www.ontologyportal.org/inference/rules/WordNet#
http://www.w3.org/2002/07/owl#
ldp
oplweb
skos-trans
virtrdf-label
None
About:
Ebola virus disease
Goto
Sponge
NotDistinct
Permalink
An Entity of Type :
schema:ScholarlyArticle
, within Data Space :
wasabi.inria.fr
associated with source
document(s)
Type:
Academic Article
research paper
schema:ScholarlyArticle
New Facet based on Instances of this Class
Attributes
Values
type
Academic Article
research paper
schema:ScholarlyArticle
isDefinedBy
Covid-on-the-Web dataset
has title
Ebola virus disease
Creator
Bollinger, Laura
Crozier, Ian
Jacob, Shevin
Kraft, Colleen
Kuhn, Jens
De, Marc-Antoine
Hewlett, Angela
Ii, William
Vega, La
Griffiths, Anthony
Soka, Moses
Wahl, Victoria
Source
PMC
abstract
Ebola virus disease (EVD) is a severe and frequently lethal disease caused by Ebola virus (EBOV). EVD outbreaks typically start from a single case of probable zoonotic transmission, followed by human-to-human transmission via direct contact or contact with infected bodily fluids or contaminated fomites. EVD has a high case–fatality rate; it is characterized by fever, gastrointestinal signs and multiple organ dysfunction syndrome. Diagnosis requires a combination of case definition and laboratory tests, typically real-time reverse transcription PCR to detect viral RNA or rapid diagnostic tests based on immunoassays to detect EBOV antigens. Recent advances in medical countermeasure research resulted in the recent approval of an EBOV-targeted vaccine by European and US regulatory agencies. The results of a randomized clinical trial of investigational therapeutics for EVD demonstrated survival benefits from two monoclonal antibody products targeting the EBOV membrane glycoprotein. New observations emerging from the unprecedented 2013–2016 Western African EVD outbreak (the largest in history) and the ongoing EVD outbreak in the Democratic Republic of the Congo have substantially improved the understanding of EVD and viral persistence in survivors of EVD, resulting in new strategies toward prevention of infection and optimization of clinical management, acute illness outcomes and attendance to the clinical care needs of patients.
has issue date
2020-02-20
(
xsd:dateTime
)
bibo:doi
10.1038/s41572-020-0147-3
bibo:pmid
32080199
has license
no-cc
sha1sum (hex)
373395340c84705638d47deb2057d48d930ca3fd
schema:url
https://doi.org/10.1038/s41572-020-0147-3
resource representing a document's title
Ebola virus disease
has PubMed Central identifier
PMC7223853
has PubMed identifier
32080199
schema:publication
Nat Rev Dis Primers
resource representing a document's body
covid:373395340c84705638d47deb2057d48d930ca3fd#body_text
is
schema:about
of
named entity 'targeting'
named entity 'antigens'
named entity 'improved'
named entity 'prevention'
named entity 'immunoassays'
named entity 'reverse transcription PCR'
named entity 'outbreak'
named entity 'typically'
named entity 'infected'
named entity 'gastrointestinal'
named entity 'typically'
named entity 'Ebola virus'
named entity 'survival'
named entity 'case-fatality rate'
named entity 'Sierra Leone'
named entity 'filovirus'
named entity 'EBOV'
named entity 'vomiting'
named entity 'virus'
named entity 'EVD'
named entity 'public health surveillance'
named entity 'Uganda'
named entity 'Democratic Republic of the Congo'
named entity 'bacterial translocation'
named entity 'social isolation'
named entity 'epidemic'
named entity 'endotracheal tube'
named entity 'Kidney'
named entity 'feces'
named entity 'EVD'
named entity 'glucose'
named entity 'IgM'
named entity 'acute kidney injury'
named entity 'blood samples'
named entity 'EBOV'
named entity 'IL-1β'
named entity 'reverse transcription'
named entity 'symptom'
named entity 'EBOV'
named entity 'EVD'
named entity 'nonhuman primates'
named entity 'uveitis'
named entity 'fever'
named entity 'EVD'
named entity '2016'
named entity 'EBOV'
named entity 'RNA'
named entity 'viral'
named entity 'fomites'
named entity 'Democratic Republic of the Congo'
named entity 'rapid diagnostic tests'
named entity 'EVD'
named entity 'EBOV'
named entity 'EVD'
named entity 'antigens'
named entity 'EVD'
named entity 'single case'
named entity 'infection'
named entity 'fever'
named entity 'Ebola virus disease'
named entity 'SUDV'
named entity 'liver'
named entity 'virus'
named entity 'Democratic Republic of the Congo'
named entity 'communicable diseases'
named entity 'FVD'
named entity 'crab-eating macaques'
named entity 'conjunctival'
named entity 'virus entry'
named entity 'International Classification of Diseases'
◂◂ First
◂ Prev
Next ▸
Last ▸▸
Page 1 of 20
Go
Faceted Search & Find service v1.13.91 as of Mar 24 2020
Alternative Linked Data Documents:
Sponger
|
ODE
Content Formats:
RDF
ODATA
Microdata
About
OpenLink Virtuoso
version 07.20.3229 as of Jul 10 2020, on Linux (x86_64-pc-linux-gnu), Single-Server Edition (94 GB total memory)
Data on this page belongs to its respective rights holders.
Virtuoso Faceted Browser Copyright © 2009-2024 OpenLink Software